BMO Capital Downgrades Regeneron Pharma (REGN) to Market Perform

April 27, 2012 7:55 AM EDT
Get Alerts REGN Hot Sheet
Price: $837.90 +3.41%

Rating Summary:
    29 Buy, 19 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 11 | Down: 9 | New: 13
Join SI Premium – FREE
BMO Capital downgraded Regeneron Pharma (NASDAQ: REGN) from Outperform to Market Perform, price target raised $1 to $143.

For an analyst ratings summary and ratings history on Regeneron Pharma click here. For more ratings news on Regeneron Pharma click here.

Shares of Regeneron Pharma closed at $138.60 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst PT Change, Downgrades

Related Entities

BMO Capital